Stay updated on Faricimab in Neovascular AMD Clinical Trial
Sign up to get notified when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.

Latest updates to the Faricimab in Neovascular AMD Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4. This reflects a new build of the site and does not modify visible content or functionality.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s release/version label was updated from “Revision: v3.5.2” to “Revision: v3.5.3,” indicating a change to the website build or documentation skin rather than the underlying clinical trial content.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check58 days agoChange DetectedPublications section updated with a new 2026 JAMA Ophthalmol. article and removal of the previously listed online-ahead-of-print version.SummaryDifference0.0%

- Check65 days agoChange DetectedSite revision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

Stay in the know with updates to Faricimab in Neovascular AMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Faricimab in Neovascular AMD Clinical Trial page.